Primary Healthcare Startups In India

India’s wealthy populations have access to some of the best healthcare in the world, with highly trained doctors and state of the art facilities. But as you move down the economic pyramid, this access disappears rapidly. And in rural areas, healthcare available to the masses has not advanced much in 50 years. This creates a huge opportunity for entrepreneurs who are developing affordable primary healthcare solutions.

Primary healthcare infrastructure in India is mostly concentrated in urban areas. There’s a pressing need to provide the rural population with access to quality and affordable services.

Karma Healthcare is trying to bridge this gap with the help of technology. The company runs clinics in rural areas       of the desert state of Rajasthan. It gives villagers access to specialised doctors through telemedicine as well as face-     to-face follow-up consultations with local or mobile clinics. It uses tablet computers and medical devices which can     transmit real-time data from patients to doctors located elsewhere.

images (2)

 Finding affordable primary medical care can be a headache for people in India. SeeDoc is one of the newest                   companies using technology to solve that problem. Based in New Delhi, its mobile app connects pre-screened               doctors and patients through video calls. the startup’s goal is to provide on-demand service. SeeDoc also has                 partnerships with pharmacies, clinics, and labs so users can get prescriptions, follow-up care, or tests if SeeDoc           also has partnerships with pharmacies, clinics, and labs so users can get prescriptions, follow-up care, or tests if           necessary. SeeDoc’s competitors include Lybrate, which is backed by Tiger Global, and iCliniq.


Healthenablr  India Pvt Ltd., a new entrant in the healthcare technology and services sector announced today that     it had recently closed an $800,000 (Rs 5.5 Cr.) seed round. The startup plans on channelling this investment to           further develop its patented Electronic Medical Records(EMR) technology and consolidate sales efforts. Based out     of Mumbai, HealthEnablr was incorporated in September 2015 by Booth School of Business graduates Bamasish         Paul and Avishek Mukherjee. Positioned as a data-driven telehealthcare company, it assists patients in connecting     with healthcare services and practitioners worldwide through its proprietary web and mobile platform.


 Manish Saraf formed Ujjeewan in West Bengal in January 2014,to address primary healthcare woes in rural parts       of the state, where there is hardly any reach of medical facility/ services. A social impact business, Ujjeewan helps       with last-mile medical services and care through telemedicine, fair price generic medicines, basic preventive                 pathological tests, women’s healthcare services, education and monitoring through women’s self-help groups               (SHGs). The centre at Raniganj sometimes gets 350-400 patients in just three hours, and on an average, clears 100     prescriptions a day. Currently, there are two operational centres, and Saraf’s calculations say the bootstrapped             company will have adequate cash flow after just five more centres, with two due to start this April.


MedGenome is a genomics-focused research and diagnostics company, on a mission to improve global health by         accelerating drug discovery research for pharma companies by decoding the genetic information contained in an         individual’s genome.The company says that it’s the only lab in India to provide a HiseQ 4000 NGS (Next                       Generation Sequencing) machine and the first to establish a facility for non-invasive prenatal testing for the                 chromosomal diseases in India.


India is far from Primary Healthcare to everyone, but these startups give us the hope that we are adapting to change and our healthcare services will be better in future.


I took prednisone advised by my doctor when I had Bell’s Palsy. It was really effective and in almost two week along with other vitamins tablets my BP got better.

But some of the side effect were:
1) Eating a lot, like whole day.
2) Sleeping problem
3) Angry and grumpy all day.

Personalized Medicine In India

Personalized medicine in India is a young but rapidly advancing field of healthcare that is informed by each person’s unique clinical, genetic, genomic, and environmental information. It is about making the treatment as individualized as the disease. It involves identifying genetic, genomic, and clinical information that allows accurate predictions to be made about a person’s susceptibility of developing the disease, the course of the disease, and its response to treatment.

Specific advantages that personalized medicine may offer patients and clinicians include:

 Ability to make more informed medical decisions

 Higher probability of desired outcomes thanks to better-targeted therapies

 Reduced probability of negative side effects

 Focus on prevention and prediction of disease rather than reaction to it

 Earlier disease intervention than has been possible in the past

 Reduced healthcare costs

Advances in Genomics Technology Have Set the Stage for a Revolution in Personal Genomics that will ultimately work towards preventive healthcare, disease burden reduction and Personalized Medicine in India. Positive hqdefaultBioscience has partnered with Medanta – The Medicity to launch India’s first personal genomics clinic, which offers state-of-the-art facilities and services in preventive healthcare and personalized medicine within the country. This partnership seeks to offer comprehensive personal genomics services to the customers along with advice from leading experts associated with the Medanta – The Medicity under one roof.

Advances in genomics now enable scientists to examine the DNA of each-and-every individual and then predict if the person would be susceptible to a particular disease or whether a particular medicine is suitable for that person in case he falls sick. This is where pharmacogenomics comes into play. Companies have started investing in pharmacogenomics as it offers several advantages such as the elimination of the unpredictable nature of drug development, bring new products to the market and the company could also benefit up to $200-to-$500 million for each drug.

main-thumb-t-265506-200-aduztyxvjxylkhxrkxzmaztfmjqdxhyxA start-up company called Xcode Lifesciences has come up with the InDNA technology to provide solutions to lifestyle-related diseases such as coronary, diabetes and obesity. A person has to order the test online after which a saliva kit will be shipped to the customer. This saliva kit is completely non-invasive and safe. DNA extracted from the saliva will then be used to determine the allelic information of the individual using high-throughput genotyping techniques.

sgdsdgssfgsdfgdNutraGene launched the country’s first commercial genetic test for type 2 diabetes. NutraGene’s Type 2 Diabetes Genetic Scan is a DNA testing service that screens DNA variations that have been widely replicated as risk factors for type 2 diabetes. It is based on a buccal (cheek) swab sample and the methodology of targeted mutation screening (genotyping).

AvesthagenAvesthagen is another major player focusing on pharmacogenomics field. One of the major projects of the company is the AVESTAGENOME Project. It is a system biology-based study of the Parsi population to determine the genetic basis of longevity and age-related disorders. This study aims to develop a model for pharmacogenomics-based therapies, development of biomarkers for predictive diagnostics and drug discovery and to enable the archiving of the genome of the community. Avesthagen started this Rs125 crore project in 2007.

Despite the optimism expressed regarding the impact that this field might have on the health of people, many barriers need to be crossed. Researchers, diagnostic firms and regulatory authorities need to establish methodologies by which to judge their effectiveness. Application of genomic and personalized medicine in India needs a change in the regulatory system.


Imagine, next time when you visit your doctor for treatment, he asks questions like –where do you live and what do you do, in addition to symptoms; before prescribing you a medicine. And ‘YES’ everything is official about it! Maybe because he wants to find the medicine that ‘FITS’ you the best. Here we are talking about the concept of Personalized Medicines wherein “one drug fits all” approach in combination with Pharmacogenomic research can evolve into an individualized approach to therapy where optimally effective drugs are matched to a patient’s unique genetic profile.